Cargando…

Low Praziquantel Treatment Coverage for Schistosoma mansoni in Mayuge District, Uganda, Due to the Absence of Treatment Opportunities, Rather Than Systematic Non-Compliance

The World Health Organization (WHO) recommends praziquantel mass drug administration (MDA) to control schistosomiasis in endemic regions. We aimed to quantify recent and lifetime praziquantel coverage, and reasons for non-treatment, at an individual level to guide policy recommendations to help Ugan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adriko, Moses, Faust, Christina L., Carruthers, Lauren V., Moses, Arinaitwe, Tukahebwa, Edridah M., Lamberton, Poppy H. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306755/ https://www.ncbi.nlm.nih.gov/pubmed/30297642 http://dx.doi.org/10.3390/tropicalmed3040111

Ejemplares similares

Residence Time, Water Contact, and Age-driven Schistosoma mansoni Infection in Hotspot Communities in Uganda
por: Moses, Arinaitwe, et al.
Publicado: (2021)

Two-year longitudinal survey reveals high genetic diversity of Schistosoma mansoni with adult worms surviving praziquantel treatment at the start of mass drug administration in Uganda
por: Faust, Christina L., et al.
Publicado: (2019)

Understanding the relationship between egg- and antigen-based diagnostics of Schistosoma mansoni infection pre- and post-treatment in Uganda
por: Prada, Joaquín M., et al.
Publicado: (2018)

Reconciling Egg- and Antigen-Based Estimates of Schistosoma mansoni Clearance and Reinfection: A Modeling Study
por: Clark, Jessica, et al.
Publicado: (2021)

Translating From Egg- to Antigen-Based Indicators for Schistosoma mansoni Elimination Targets: A Bayesian Latent Class Analysis Study
por: Clark, Jessica, et al.
Publicado: (2022)

Impacts of host gender on Schistosoma mansoni risk in rural Uganda—A mixed-methods approach
por: Trienekens, Suzan C. M., et al.
Publicado: (2020)

Reduced Efficacy of Praziquantel Against Schistosoma mansoni Is Associated With Multiple Rounds of Mass Drug Administration
por: Crellen, Thomas, et al.
Publicado: (2016)

The effects of subcurative praziquantel treatment on life‐history traits and trade‐offs in drug‐resistant Schistosoma mansoni
por: Viana, Mafalda, et al.
Publicado: (2017)

ABO Blood Groups Do Not Predict Schistosoma mansoni Infection Profiles in Highly Endemic Villages of Uganda
por: Francoeur, Rachel, et al.
Publicado: (2021)

The impact of storage conditions on human stool 16S rRNA microbiome composition and diversity
por: Carruthers, Lauren V., et al.
Publicado: (2019)

Praziquantel decreases fecundity in Schistosoma mansoni adult worms that survive treatment: evidence from a laboratory life-history trade-offs selection study
por: Lamberton, Poppy H.L., et al.
Publicado: (2017)

Effect of water temperature and population density on the population dynamics of Schistosoma mansoni intermediate host snails
por: McCreesh, Nicky, et al.
Publicado: (2014)

Regression of Schistosoma mansoni associated morbidity among Ugandan preschool children following praziquantel treatment: A randomised trial
por: Nalugwa, Allen, et al.
Publicado: (2021)

Whole-genome sequencing of Schistosoma mansoni reveals extensive diversity with limited selection despite mass drug administration
por: Berger, Duncan J., et al.
Publicado: (2021)

Variation in water contact behaviour and risk of Schistosoma mansoni (re)infection among Ugandan school-aged children in an area with persistent high endemicity
por: Trienekens, Suzan C. M., et al.
Publicado: (2022)

In Vitro Praziquantel Test Capable of Detecting Reduced In Vivo Efficacy in Schistosoma mansoni Human Infections
por: Lamberton, Poppy H. L., et al.
Publicado: (2010)

Risk assessment for the implementation of controlled human Schistosoma mansoni infection trials in Uganda
por: Koopman, Jan Pieter, et al.
Publicado: (2019)

Single Versus Double Dose Praziquantel Comparison on Efficacy and Schistosoma mansoni Re-Infection in Preschool-Age Children in Uganda: A Randomized Controlled Trial
por: Nalugwa, Allen, et al.
Publicado: (2015)

Sensitivity and Specificity of Multiple Kato-Katz Thick Smears and a Circulating Cathodic Antigen Test for Schistosoma mansoni Diagnosis Pre- and Post-repeated-Praziquantel Treatment
por: Lamberton, Poppy H. L., et al.
Publicado: (2014)

Human IgG(1) Responses to Surface Localised Schistosoma mansoni Ly6 Family Members Drop following Praziquantel Treatment
por: Chalmers, Iain W., et al.
Publicado: (2015)

Harnessing technology and portability to conduct molecular epidemiology of endemic pathogens in resource-limited settings
por: Faust, Christina L, et al.
Publicado: (2020)

Impact of a national deworming campaign on the prevalence of soil-transmitted helminthiasis in Uganda (2004-2016): Implications for national control programs
por: Adriko, Moses, et al.
Publicado: (2018)

Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel
por: Amer, Eglal I., et al.
Publicado: (2022)

THE SUSCEPTIBILITY OF RECENT ISOLATES OF Schistosoma mansoni TO PRAZIQUANTEL
por: MENDONÇA, Adriana Maria B., et al.
Publicado: (2016)

Praziquantel Treatment Decreases Schistosoma mansoni Genetic Diversity in Experimental Infections
por: Coeli, Regina, et al.
Publicado: (2013)

Effect of Dihydroartemisinin-Piperaquine on the Pharmacokinetics of Praziquantel for Treatment of Schistosoma mansoni Infection
por: Minzi, Omary Mashiku, et al.
Publicado: (2021)

Schistosoma mansoni Infections in Young Children: When Are Schistosome Antigens in Urine, Eggs in Stool and Antibodies to Eggs First Detectable?
por: Stothard, J. Russell, et al.
Publicado: (2011)

Antibody responses to Schistosoma mansoni schistosomula antigens
por: Egesa, Moses, et al.
Publicado: (2018)

Correction: Schistosoma mansoni Infections in Young Children: When Are Schistosome Antigens in Urine, Eggs in Stool and Antibodies to Eggs First Detectable?
por: Stothard, J. Russell, et al.
Publicado: (2012)

Synergy of Omeprazole and Praziquantel In Vitro Treatment against Schistosoma mansoni Adult Worms
por: Almeida, Giulliana T., et al.
Publicado: (2015)

The Role of Efflux Pumps in Schistosoma mansoni Praziquantel Resistant Phenotype
por: Pinto-Almeida, António, et al.
Publicado: (2015)

Investigations on the interplays between Schistosoma mansoni, praziquantel and the gut microbiome
por: Schneeberger, Pierre H. H., et al.
Publicado: (2018)

A single locus determines praziquantel response in Schistosoma mansoni
por: Chevalier, Frédéric D., et al.
Publicado: (2023)

Efficacy and Safety of Praziquantel for Treatment of Schistosoma mansoni Infection among School Children in Tanzania
por: Mnkugwe, Rajabu Hussein, et al.
Publicado: (2019)

Praziquantel Treatment of Schistosoma mansoni Infected Mice Renders Them Less Susceptible to Reinfection
por: Nono, Justin Komguep, et al.
Publicado: (2021)

Schistosoma mansoni-Associated Morbidity among Preschool-Aged Children along the Shores of Lake Victoria in Uganda
por: Nalugwa, Allen, et al.
Publicado: (2017)

Schistosoma mansoni schistosomula antigens induce Th1/Pro‐inflammatory cytokine responses
por: Egesa, Moses, et al.
Publicado: (2018)

Understanding perceptions of schistosomiasis and its control among highly endemic lakeshore communities in Mayuge, Uganda
por: Mujumbusi, Lazaaro, et al.
Publicado: (2023)

The praziquantel in preschoolers (PIP) trial: study protocol for a phase II PK/PD-driven randomised controlled trial of praziquantel in children under 4 years of age
por: Webb, Emily L., et al.
Publicado: (2021)

Effect of Maternal Schistosoma mansoni Infection and Praziquantel Treatment During Pregnancy on Schistosoma mansoni Infection and Immune Responsiveness among Offspring at Age Five Years
por: Tweyongyere, Robert, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_u6pervpqlsulptri63vgs6b9u3